Journals / Türk Biyokimya Dergisi / 2018 / Cilt: 43 - Sayı: 1

Evaluation of vascular endothelial growth factor levels in rheumatoid arthritis patients, with and without joint swelling; a comparison with erythrocyte sedimentation rate, C-reactive protein, rheumatoid factor and anti-cyclic citruillnated protein

Eklem Şişliği Olan ve Olmayan Romatoid Artritli Hastalarda Vasküler Endoteliyal Büyüme Faktörü Düzeyleri ve Eritrosit Sedimantasyon Hızı, C-Reaktif Protein ve Anti-Siklik Sitrülinlenmiş Protein Düzeyleri ile Karşılaştırılması

Pages
76–82
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The area underthe curve was calculated to be 0.767.Conclusion: Vascular endothelial growth factor is an adequatediagnostic biomarker and can successfully be usedto predict the occurrence of rheumatoid synovitis basedon local inflammation.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: The aim of our study was to investigate thevascular endothelial growth factor levels in joint swellingpositiveand joint swelling-negative rheumatoid arthritispatients and to then examine the relationship betweenconventional parameters such as the erythrocyte sedimentationrate and the levels of C-reactive protein, rheumatoidfactor, and anti-cyclic citrullinated protein.Methods: Fifty-nine (52 women and seven men) rheumatoidarthritis patients and 25 (20 women and five men)healthy individuals volunteered for this study.
📊
Key Findings & Data:The patientgroup was divided into two sub-groups based on whetheror not they exhibited joint swelling.Results: The levels of vascular endothelial growth factorin the joint swelling-negative group were significantly differentfrom those in the joint swelling-positive group, butthey were not different from those in the control group(p = 0.001 and p = 0.72, respectively).
💡
Conclusion & Impact:The area underthe curve was calculated to be 0.767.Conclusion: Vascular endothelial growth factor is an adequatediagnostic biomarker and can successfully be usedto predict the occurrence of rheumatoid synovitis basedon local inflammation.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: The aim of our study was to investigate thevascular endothelial growth factor levels in joint swellingpositiveand joint swelling-negative rheumatoid arthritispatients and to then examine the relationship betweenconventional parameters such as the erythrocyte sedimentationrate and the levels of C-reactive protein, rheumatoidfactor, and anti-cyclic citrullinated protein.Methods: Fifty-nine (52 women and seven men) rheumatoidarthritis patients and 25 (20 women and five men)healthy individuals volunteered for this study. The patientgroup was divided into two sub-groups based on whetheror not they exhibited joint swelling.Results: The levels of vascular endothelial growth factorin the joint swelling-negative group were significantly differentfrom those in the joint swelling-positive group, butthey were not different from those in the control group(p = 0.001 and p = 0.72, respectively). We investigated thecorrelation between vascular endothelial growth factorand C-reactive protein levels (r = 0.37, p = 0.001). We alsoevaluated the diagnostic adequacy of vascular endothelialgrowth factor and created a ROC curve. The area underthe curve was calculated to be 0.767.Conclusion: Vascular endothelial growth factor is an adequatediagnostic biomarker and can successfully be usedto predict the occurrence of rheumatoid synovitis basedon local inflammation.

Özet

Giriş ve amaç: Çalışmamızın amacı eklem şişliği olan ve olmayan romatoid artritli hastalarda Vasküler Endotelyal Büyüme Faktörü düzeylerinin araştırılması ve romatoid artrit tanı ve takibinde konvansiyonel parametreler olan Eritrosit Sedimantasyon Hızı, C-Reaktif Protein, Romatoid Faktör ve Anti-siklik Sitrülinlenmiş Protein düzeyleri ile ilişkisi olup olmadığının incelenmesidir. Yöntem ve gereçler: Elli dokuz (52 kadın ve 7 erkek) romatoid artritli hasta ve 25 ( 20 kadın ve 5 erkek) sağlıklı kişi çalışmaya gönüllü olarak katıldı. Hasta grubu eklem şişliği olması ve eklem şişliği olmamasına göre alt gruplara ayrıldı. Bulgular: Eklem şişliği negatif olan grup eklem şişliği pozitif olan gruptan anlamlı şekilde farklıyken, kontrol grubu ile aralarında istatistiksel olarak fark olmadığını gözlendi (p = 0.001 ve p = 0.72, sırasıyla). Vasküler Endotelyal Büyüme Faktörü ve C-Reaktif Protein düzeyleri arasında korelasyon olduğunu saptandı (r = 0.37, p = 0.001). Çalışmamızda Vasküler Endotelyal Büyüme Faktörü’nün tanısal yeterliği değerlendirilmesi için ROC eğrisi oluşturuldu. Eğri altında kalan alan 0.767 olarak hesaplandı. Tartışma ve sonuç: Vasküler Endotelyal Büyüme Faktörü romatoid artrite bağlı olarak gelişen lokal enflasyonun belirlenmesinde kullanılabilecek bir biyobelirteçtir.

🔖

Cite This Article

SEVAL, H., İNAL, B. B., COŞKUN, C., EMRE, H. Ö., DÖVENTAŞ, Y. E., TEMEL, M., KOLDAŞ, M., GÜMÜŞ, A. (2022). Evaluation of vascular endothelial growth factor levels in rheumatoid arthritis patients, with and without joint swelling; a comparison with erythrocyte sedimentation rate, C-reactive protein, rheumatoid factor and anti-cyclic citruillnated protein. Türk Biyokimya Dergisi, Cilt: 43 - Sayı: 1, 76–82. https://ajindex.com/articles/620977

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Mclnes IB, Schett B. The pathogenesis of rhematoid arthritis. N Eng J Med 2011;365:2205–19
  2. Akar S, Birlik M. The prevalence of rheumatoid arthritis in an urban population of Izmir-Turkey. Clin Exp Rheumatol 2004;22:416–20
  3. Kacar C, Gilgil E. Prevalence of rheumatoid arthritis in Antalya, Turkey. Clin Rheumatol 2005;24:212–4
  4. Çapkin E, Cakirbay H. Prevalence of rheumatoid arthritis in the eastern Black Sea region of Turkey. Int J Rheum Dis 2010;13:380–4
  5. Szekanecz Z, Besenyeia T. New insights in synovial angiogenesis. Joint Bone Spine 2010;77:13–9
  6. Kong X, Zhang Y. Anti-angiogenic effect of triptolide in rheumatoid arthritis by targeting angiogenic cascade. PLoS One 2013;8:e77513
  7. Walsh AD, McWilliams DF. Angiogenesis and nerve growth factor at the osteochondral junction in rheumatoid arthritis and osteoarthritis. Rheumatology 2010;49:1852–61
  8. Tang X, Yang Y. Novel transcriptional regulation of VEGF in inflammatory processes. J Cell Mol Med 2013;17:386–97
  9. Hetland M, Christensen IJ. Circulating VEGF as a biological marker in patients with rheumatoid arthritis? Preanalytical and biological variability in healthy persons and in patients. Dis Markers 2008;24:1–10
  10. Rivera C, Mellberg S. Analysis of VEGF-A regulated gene expression in endothelial cells to identify genes linked to angiogenesis. PLoS One 2011;6:e24887
  11. Harper SJ, Bates DO. VEGF-A splicing: the key to anti-angiogenic therapeutics? Nat Rev Cancer 2008;8:880–7
  12. Hoeben A, Landuyt B. Vascular endothelial growth factor and angiogenesis. Pharmacol Rev 2004;56:549–80
  13. Amos RS, Constable TJ. Rheumatoid arthritis: relation of serum C-reactive protein and erythrocyte sedimentation rates to radiographic changes. Br Med J 1977;22:195–7
  14. SiemonsL, ten Klooster PM. How age and sex affect the erythrocyte sedimentation rate and C-reactive protein in early rheumatoid arthritis. BMC Musculoskelet Disord 2014;15:368
  15. Kim KW, Kim BM. Role of C-reactive protein in osteoclastogenesis in rheumatoid arthritis. Arthritis Res Ther 2015;17:41
  16. Pike RM, Sulkin SE. Concerning the nature of the factor in rheumatoid- arthritis serum responsible for increased agglutination of sensitized sheep erythrocytes. J Immunol 1949;63:447–63
  17. Vossenaar ER, Smeets TJ. The presence of citrullinated proteins is not specific for rheumatoid synovial tissue. Arthritis Rheum 2004;50:3485–94
  18. Makrygiannakis D, af Klint E, Lundberg IE, Löfberg R, Ulfgren AK, Klareskog L, et al. Citrulli